Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Deng

Showing results (121-130 of 988) with videos related to

Pageof 99
Sort By:
Journal of Clinical Psychopharmacology|July 16, 2010
What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?Chao Deng, Jiezhong Chen, Changhua Hu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2014
Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brainsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Pharmacological Research|March 19, 2015
Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathwaysJiamei Lian, Michael De Santis, Meng He, et al.
Psychoneuroendocrinology|July 4, 2014
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathwaysJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Studies in Health Technology and Informatics|August 8, 2025
Pilot Application of a Large Language Model to Identify Hospitalisation from Unstructured Electronic Health Records in Residential Aged Care FacilitiesMehtab Kiran Suddle, Ping Yu, Dinithi Vithanage, et al.
Plos One|August 2, 2014
Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatmentJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Psychopharmacology|February 8, 2013
Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathwayChao Deng, Bo Pan, Martin Engel, et al.
Pharmacological Research|February 20, 2016
Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implicationsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Journal of Molecular Neuroscience : MN|February 20, 2016
Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of RatsBo Pan, Jiamei Lian, Xu-Feng Huang, et al.
Pharmacological Research|July 29, 2015
Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathwaysXuemei Liu, Jiamei Lian, Chang-Hua Hu, et al.
Pageof 99

Showing results (121-130 of 988) with videos related to

Sort By:
Pageof 99
Journal of Clinical Psychopharmacology|July 16, 2010
What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?Chao Deng, Jiezhong Chen, Changhua Hu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 24, 2014
Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brainsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Pharmacological Research|March 19, 2015
Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathwaysJiamei Lian, Michael De Santis, Meng He, et al.
Psychoneuroendocrinology|July 4, 2014
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathwaysJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Studies in Health Technology and Informatics|August 8, 2025
Pilot Application of a Large Language Model to Identify Hospitalisation from Unstructured Electronic Health Records in Residential Aged Care FacilitiesMehtab Kiran Suddle, Ping Yu, Dinithi Vithanage, et al.
Plos One|August 2, 2014
Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatmentJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Psychopharmacology|February 8, 2013
Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathwayChao Deng, Bo Pan, Martin Engel, et al.
Pharmacological Research|February 20, 2016
Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implicationsJiamei Lian, Xu-Feng Huang, Nagesh Pai, et al.
Journal of Molecular Neuroscience : MN|February 20, 2016
Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of RatsBo Pan, Jiamei Lian, Xu-Feng Huang, et al.
Pharmacological Research|July 29, 2015
Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathwaysXuemei Liu, Jiamei Lian, Chang-Hua Hu, et al.
Pageof 99